Acquired
Novo Nordisk (Ozempic)
David Rosenthal
Yeah, wild. And they drove each other to create all of this innovation over the years. So the new combined company has roughly a billion dollars in insulin revenue and 50%, 5-0% global market share, with Eli Lilly just behind at 45% and Hosted at 5%. That kind of tells you right there how much the market has grown just during the decade of the 1980s.
0
💬
0
Comments
Log in to comment.
There are no comments yet.